Hims & Hers Health (HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS

Hagens Berman announced a securities class action against Hims & Hers Health tied to the FTC's July 29, 2026 federal complaint, which was joined by Utah and Los Angeles County. The release alleges Hims shared sensitive health data with ad platforms including Meta and Snap, and enrolled consumers in subscriptions without informed consent in violation of ROSCA. HIMS shares fell $4.32 (-14.7%) on the complaint's filing, erasing over $970 million in market cap; the lead plaintiff deadline is Nov. 2, 2026.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.